Return On Equity of Coeptis Therapeutics Inc. from 30 Jun 2020 to 30 Sep 2022

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Coeptis Therapeutics Inc. quarterly and annual Return On Equity in % history and change rate from 30 Jun 2020 to 30 Sep 2022.
  • Coeptis Therapeutics Inc. Return On Equity for the quarter ending 30 Sep 2022 was -1111%, a 361% decline year-over-year.
  • Coeptis Therapeutics Inc. annual Return On Equity for 2021 was 1836%, a 483% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Coeptis Therapeutics Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2022 -1111% -1537% -361% 01 Jul 2022 30 Sep 2022
Q2 2022 -2063% -2263% -1135% 01 Apr 2022 30 Jun 2022
Q1 2022 -3933% -4076% -2839% 01 Jan 2022 31 Mar 2022
Q4 2021 1836% +1667% +991% 01 Oct 2021 31 Dec 2021
Q3 2021 426% +110% +35% 01 Jul 2021 30 Sep 2021
Q2 2021 199% -201% -50% 01 Apr 2021 30 Jun 2021
Q1 2021 144% 01 Jan 2021 31 Mar 2021
Q4 2020 168% 01 Sep 2020 30 Nov 2020
Q3 2020 316% 01 Jul 2020 30 Sep 2020
Q2 2020 401% 01 Apr 2020 30 Jun 2020

Coeptis Therapeutics Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2021 1836% +1521% +483% 01 Jan 2021 31 Dec 2021
2020 315% 01 Jan 2020 31 Dec 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.